Federal award
ERYTHRYX THERAPEUTICS LLC
W81XWH20C0047
Contract
Obligated and Ceiling
- Obligated (net)
- $522,337.35
- Ceiling (potential value, not spending)
- $522,337.35
- Current value
- $522,337.35
- Gross positive obligations
- $522,337.35
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ERYTHRYX THERAPEUTICS LLC · EHM2GT3A1U99
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ERYTHRYX THERAPEUTICS LLC · EHM2GT3A1U99
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- W81XWH20C0047
- Award type code
- D
- Actions
- 5 · Mar 18, 2020 to Feb 1, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 1, 2022 | FY2022 | P00004 | B | $0.00 | — |
| Jun 17, 2021 | FY2021 | P00003 | B | $0.00 | — |
| Nov 12, 2020 | FY2021 | P00002 | B | $0.00 | — |
| Apr 16, 2020 | FY2020 | P00001 | D | $0.00 | — |
| Mar 18, 2020 | FY2020 | 0 | — | $522,337.35 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.